Abstract

The purpose of this contract is to develop an innovative preventive HIV vaccine concept into a HIV Vaccine product(s) suitable for testing in humans. The contractor is required to enter into a HIV Vaccine product into a clinical trial by the fifth year.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272200800063C-1-0-1
Application #
7941291
Study Section
Project Start
2008-09-30
Project End
2015-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2009
Total Cost
$6,573,776
Indirect Cost

  Institution

Name
Viral Genomix, Inc.
Department
Type
DUNS #
063784784
City
Blue Bell
State
PA
Country
United States
Zip Code
19422